mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |
mRNA |
lapatinib |
CCLE |
pan-cancer |
AAC |
-0.14 |
0.002 |
mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.003 |
mRNA |
MLN2480 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.003 |
mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.004 |
mRNA |
17-AAG |
CCLE |
pan-cancer |
AAC |
-0.14 |
0.004 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.004 |
mRNA |
chlorambucil |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.004 |
mRNA |
MLN4924 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.005 |
mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.005 |